These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3220966)

  • 1. The prevalence of tardive dyskinesia in fluphenazine-treated patients.
    Yassa R; Iskandar H; Ally J
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):17S-20S. PubMed ID: 3220966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tardive dyskinesia in outpatients on depot phenothiazine.
    Neehall J
    West Indian Med J; 1989 Dec; 38(4):228-33. PubMed ID: 2576166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monkey model of tardive dyskinesia (TD): evidence that reversible TD may turn into irreversible TD.
    Kovacic B; Domino EF
    J Clin Psychopharmacol; 1982 Oct; 2(5):305-7. PubMed ID: 6890075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of tardive dyskinesia development: preliminary results.
    Kane JM; Woerner M; Weinhold P; Wegner J; Kinon B
    J Clin Psychopharmacol; 1982 Oct; 2(5):345-9. PubMed ID: 6127353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High incidence of tardive dyskinesia in older outpatients on low doses of neuroleptics.
    Harris MJ; Panton D; Caligiuri MP; Krull AJ; Tran-Johnson TK; Jeste DV
    Psychopharmacol Bull; 1992; 28(1):87-92. PubMed ID: 1609047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Movement disorders in patients treated with long-acting injectable antipsychotic drugs.
    Bransgrove LL; Kelly MW
    Am J Hosp Pharm; 1994 Apr; 51(7):895-9. PubMed ID: 7912473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluphenazine decanoate and tardive dyskinesia: a possible association.
    Csernansky JG; Grabowski K; Cervantes J; Kaplan J; Yesavage JA
    Am J Psychiatry; 1981 Oct; 138(10):1362-5. PubMed ID: 7294195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tardive dyskinesia in India: a prevalence study.
    Doongaji DR; Jeste DV; Jape NM; Sheth AS; Apte JS; Vahia VN; Desai AB; Vahora SA; Thatte S; Vevaina T; Bharadwaj J
    J Clin Psychopharmacol; 1982 Oct; 2(5):341-4. PubMed ID: 6127352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The opiate antagonist naloxone suppresses a rodent model of tardive dyskinesia.
    Stoessl AJ; Polanski E; Frydryszak H
    Mov Disord; 1993 Oct; 8(4):445-52. PubMed ID: 7901759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM; Annable L; Bélanger MC; Chouinard G
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tardive dyskinesia in the course of antidepressant therapy: a prevalence study and review of the literature.
    Yassa R; Camille Y; Belzile L
    J Clin Psychopharmacol; 1987 Aug; 7(4):243-6. PubMed ID: 3624506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tardive dyskinesia: prevalence and risk factors, 1959 to 1979.
    Kane JM; Smith JM
    Arch Gen Psychiatry; 1982 Apr; 39(4):473-81. PubMed ID: 6121548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tardive dyskinesia.
    Soares-Weiser K; Fernandez HH
    Semin Neurol; 2007 Apr; 27(2):159-69. PubMed ID: 17390261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 5-year prospective longitudinal study of tardive dyskinesia: factors predicting appearance of new cases.
    Chouinard G; Annable L; Ross-Chouinard A; Mercier P
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):21S-26S. PubMed ID: 3220967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tardive dyskinesia in psychiatric outpatients: a study of prevalence and association with demographic, clinical, and drug history variables.
    Mukherjee S; Rosen AM; Cardenas C; Varia V; Olarte S
    Arch Gen Psychiatry; 1982 Apr; 39(4):466-9. PubMed ID: 6121547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes is not a risk factor for tardive dyskinesia: a retrospective observational study.
    Raja M; Azzoni A
    Hum Psychopharmacol; 2002 Jan; 17(1):61-3. PubMed ID: 12404708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tardive dyskinesia: determinants of temporal dynamics of its emergence.
    Latalova K
    Neuro Endocrinol Lett; 2008 Dec; 29(6):995-8. PubMed ID: 19112392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variables.
    Ezrin-Waters C; Seeman MV; Seeman P
    J Clin Psychiatry; 1981 Jan; 42(1):16-22. PubMed ID: 6109715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early course of new-onset tardive dyskinesia in older patients.
    Lacro JP; Gilbert PL; Paulsen JS; Fell R; Bailey A; Juels C; Caligiuri M; McAdams LA; Harris MJ; Jeste DV
    Psychopharmacol Bull; 1994; 30(2):187-91. PubMed ID: 7831454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of tardive dyskinesia in patients receiving depot neuroleptic injection.
    Gibson AC
    Acta Psychiatr Scand Suppl; 1981; 291():111-6. PubMed ID: 6113729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.